Calculating potential doubling time using monoclonal antibodies specific for two halogenated thymidine analogues

Alan Pollack, R. Allen White, Shilong Cao, Marvin L. Meistrich, Nicholas H A Terry

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Purpose: A new flow cytometric technique that allows for two incorporated thymidine analogues to be measured simultaneously and independently has been used to improve the accuracy of in vivo cell kinetic estimates, i.e., the length of S-phase (TS) and potential doubling time (Tpot). Methods and Materials: The analogues chlorodeoxyuridine and iododeoxyuridine were injected at different times into mice bearing the mouse mammary tumor MCaK. At different times after labeling, the tumors were harvested and prepared for three color flow cytometric analysis of DNA, chlorodeoxyuridine, and iododeoxyuridine. Control experiments showed that similar estimates of Tpot were obtained from each label when administered singly, or as staggered pulses. Comparisons were made between Ts and Tpot calculated from a single label (single point), from the averaged result of the two labels from the same tumor (two point-ave), and from the simultaneous nonlinear fitting of the measured parameters from the two labels, from the same tumor (two point-fit). These estimates of Ts and Tpot were then compared to reference values obtained by fitting the pooled measured parameters from all the tumors, that were labeled for different periods of time. Results: While all of the methods resulted in similar mean estimates of Ts and Tpot that were close to the reference values, the fewest assumptions, and the least variability in the results, were obtained using the two point-fit data. Conclusion: The estimation of Tpot using two thymidine analogues is more accurate than that obtained from a single label.

Original languageEnglish
Pages (from-to)1131-1139
Number of pages9
JournalInternational journal of radiation oncology, biology, physics
Volume27
Issue number5
DOIs
StatePublished - Dec 1 1993
Externally publishedYes

Fingerprint

thymidine
antibodies
Thymidine
Monoclonal Antibodies
analogs
tumors
Idoxuridine
estimates
mice
Neoplasms
Reference Values
S Phase
marking
Birds
deoxyribonucleic acid
Color
Breast Neoplasms
color

Keywords

  • Chlorodeoxyuridine
  • DNA
  • Flow cytometry
  • Iododeoxyuridine
  • Potential doubling time

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Radiation

Cite this

Calculating potential doubling time using monoclonal antibodies specific for two halogenated thymidine analogues. / Pollack, Alan; Allen White, R.; Cao, Shilong; Meistrich, Marvin L.; Terry, Nicholas H A.

In: International journal of radiation oncology, biology, physics, Vol. 27, No. 5, 01.12.1993, p. 1131-1139.

Research output: Contribution to journalArticle

Pollack, Alan ; Allen White, R. ; Cao, Shilong ; Meistrich, Marvin L. ; Terry, Nicholas H A. / Calculating potential doubling time using monoclonal antibodies specific for two halogenated thymidine analogues. In: International journal of radiation oncology, biology, physics. 1993 ; Vol. 27, No. 5. pp. 1131-1139.
@article{33296f6a2deb4af98bf010c2bf0ab906,
title = "Calculating potential doubling time using monoclonal antibodies specific for two halogenated thymidine analogues",
abstract = "Purpose: A new flow cytometric technique that allows for two incorporated thymidine analogues to be measured simultaneously and independently has been used to improve the accuracy of in vivo cell kinetic estimates, i.e., the length of S-phase (TS) and potential doubling time (Tpot). Methods and Materials: The analogues chlorodeoxyuridine and iododeoxyuridine were injected at different times into mice bearing the mouse mammary tumor MCaK. At different times after labeling, the tumors were harvested and prepared for three color flow cytometric analysis of DNA, chlorodeoxyuridine, and iododeoxyuridine. Control experiments showed that similar estimates of Tpot were obtained from each label when administered singly, or as staggered pulses. Comparisons were made between Ts and Tpot calculated from a single label (single point), from the averaged result of the two labels from the same tumor (two point-ave), and from the simultaneous nonlinear fitting of the measured parameters from the two labels, from the same tumor (two point-fit). These estimates of Ts and Tpot were then compared to reference values obtained by fitting the pooled measured parameters from all the tumors, that were labeled for different periods of time. Results: While all of the methods resulted in similar mean estimates of Ts and Tpot that were close to the reference values, the fewest assumptions, and the least variability in the results, were obtained using the two point-fit data. Conclusion: The estimation of Tpot using two thymidine analogues is more accurate than that obtained from a single label.",
keywords = "Chlorodeoxyuridine, DNA, Flow cytometry, Iododeoxyuridine, Potential doubling time",
author = "Alan Pollack and {Allen White}, R. and Shilong Cao and Meistrich, {Marvin L.} and Terry, {Nicholas H A}",
year = "1993",
month = "12",
day = "1",
doi = "10.1016/0360-3016(93)90534-3",
language = "English",
volume = "27",
pages = "1131--1139",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Calculating potential doubling time using monoclonal antibodies specific for two halogenated thymidine analogues

AU - Pollack, Alan

AU - Allen White, R.

AU - Cao, Shilong

AU - Meistrich, Marvin L.

AU - Terry, Nicholas H A

PY - 1993/12/1

Y1 - 1993/12/1

N2 - Purpose: A new flow cytometric technique that allows for two incorporated thymidine analogues to be measured simultaneously and independently has been used to improve the accuracy of in vivo cell kinetic estimates, i.e., the length of S-phase (TS) and potential doubling time (Tpot). Methods and Materials: The analogues chlorodeoxyuridine and iododeoxyuridine were injected at different times into mice bearing the mouse mammary tumor MCaK. At different times after labeling, the tumors were harvested and prepared for three color flow cytometric analysis of DNA, chlorodeoxyuridine, and iododeoxyuridine. Control experiments showed that similar estimates of Tpot were obtained from each label when administered singly, or as staggered pulses. Comparisons were made between Ts and Tpot calculated from a single label (single point), from the averaged result of the two labels from the same tumor (two point-ave), and from the simultaneous nonlinear fitting of the measured parameters from the two labels, from the same tumor (two point-fit). These estimates of Ts and Tpot were then compared to reference values obtained by fitting the pooled measured parameters from all the tumors, that were labeled for different periods of time. Results: While all of the methods resulted in similar mean estimates of Ts and Tpot that were close to the reference values, the fewest assumptions, and the least variability in the results, were obtained using the two point-fit data. Conclusion: The estimation of Tpot using two thymidine analogues is more accurate than that obtained from a single label.

AB - Purpose: A new flow cytometric technique that allows for two incorporated thymidine analogues to be measured simultaneously and independently has been used to improve the accuracy of in vivo cell kinetic estimates, i.e., the length of S-phase (TS) and potential doubling time (Tpot). Methods and Materials: The analogues chlorodeoxyuridine and iododeoxyuridine were injected at different times into mice bearing the mouse mammary tumor MCaK. At different times after labeling, the tumors were harvested and prepared for three color flow cytometric analysis of DNA, chlorodeoxyuridine, and iododeoxyuridine. Control experiments showed that similar estimates of Tpot were obtained from each label when administered singly, or as staggered pulses. Comparisons were made between Ts and Tpot calculated from a single label (single point), from the averaged result of the two labels from the same tumor (two point-ave), and from the simultaneous nonlinear fitting of the measured parameters from the two labels, from the same tumor (two point-fit). These estimates of Ts and Tpot were then compared to reference values obtained by fitting the pooled measured parameters from all the tumors, that were labeled for different periods of time. Results: While all of the methods resulted in similar mean estimates of Ts and Tpot that were close to the reference values, the fewest assumptions, and the least variability in the results, were obtained using the two point-fit data. Conclusion: The estimation of Tpot using two thymidine analogues is more accurate than that obtained from a single label.

KW - Chlorodeoxyuridine

KW - DNA

KW - Flow cytometry

KW - Iododeoxyuridine

KW - Potential doubling time

UR - http://www.scopus.com/inward/record.url?scp=0027439041&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027439041&partnerID=8YFLogxK

U2 - 10.1016/0360-3016(93)90534-3

DO - 10.1016/0360-3016(93)90534-3

M3 - Article

VL - 27

SP - 1131

EP - 1139

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

IS - 5

ER -